From: Clinical treatment reverses attentional deficits in congestive heart failure
CHF (n = 50) | Controls (n = 30) | Statistic | p | |
---|---|---|---|---|
Ejection fraction (mean) | 37.0 | 74.2 | t = 6.1 | <0.001 |
CI | 35.2 – 38.7 | 72.7 – 75.6 | ||
Age (mean years) | 67.3 | 76.7 | t = 6.1 | <0.001 |
CI | 65.6 – 69.0 | 73.8 – 79.5 | ||
Male gender (%) | 76.0 | 66.7 | Χ2 = 0.8 | 0.365 |
Cerebrovascular symptoms (%) | 16.0 | 13.3 | Χ2 = 0.1 | 0.476 |
Sleep difficulties (%) | 16.0 | 36.7 | Χ2 = 4.4 | 0.035 |
Depression (%) | 0 | 3.3 | FET | 0.375 |
Anxiety (%) | 26.0 | 30.0 | Χ2 = 0.1 | 0.698 |
Memory complaints (%) | 18.0 | 40.0 | Χ2 = 4.7 | 0.030 |
Paranoid symptoms (%) | 0 | 3.3 | FET | 0.375 |
Prior myocardial infarction (%) | 38.0 | 10.0 | Χ2 = 7.4 | 0.007 |
Hypertension (%) | 64.0 | 50.0 | Χ2 = 1.5 | 0.218 |
Prior stroke (%) | 14.0 | 0 | FET | 0.041 |
Current or previous smoking (%) | 52.0 | 23.3 | Χ2 = 6.4 | 0.012 |
Regular use of alcohol (%) | 28.0 | 0 | FET | 0.001 |
Prior psychiatric history (%) | 0 | 0 | - | - |